SGK1 inhibition attenuated the action potential duration in patient- and genotype-specific re-engineered heart cells with congenital long QT syndrome

Maengjo Kim(Mayo Clinic), Michael J. Ackerman(Mayo Clinic)

Heart Rhythm O2

February 15, 2023

10.1016/j.hroo.2023.02.003

Cited by 11

Related Papers

Truncations of Titin Causing Dilated Cardiomyopathy

|New England Journal of Medicine|2012|1.5k

HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies: This document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA)

|EP Europace|2011|899

Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy

|Nature Genetics|2007|702

Disrupted Junctional Membrane Complexes and Hyperactive Ryanodine Receptors After Acute Junctophilin Knockdown in Mice

|Circulation|2011|258

Calmodulin mutations and life-threatening cardiac arrhythmias: insights from the International Calmodulinopathy Registry

|European Heart Journal|2019|184